Topics

Meningioma | Treatment | Clinical trials | Regorafenib

Home > Publications > Topics > Meningioma > Treatment > Clinical trials > Regorafenib

Bosio A, Cerretti G, Padovan M, Del Bianco P, Polano M, Mandruzzato S, Indraccolo S, Manara R, Librizzi G, Caccese M, Corrà M, Maccari M, Lonardi S, De Salvo GL, Lombardi G.
Regorafenib versus local standard of care in patients with grade 2-3 meningioma no longer eligible for loco-regional treatments: a phase II randomized controlled trial (the MIRAGE study).
Trials. 2025 Aug 4;26(1):268. doi: 10.1186/s13063-025-08997-2. PMID: 40759981. Interventional study protocol. ˍ AI Overview